Isto Biologics Launches Precise – the Newest Advancement in Autologous Therapies
Isto Biologics, a leader in orthobiologic regeneration technologies and cell-based therapies that focuses on helping patients heal faster, announced today the launch of Precise™, a brand-new,...
Royal Biologics Announces U.S. Commercial Launch of BIOINCYTE™ PRFM
Royal Biologics, a company specializing in Advanced Cellular Technologies & Enhanced Autologous Solutions, today announces the commercial launch of BIOINCYTE™ PRFM, a next-generation Platelet Rich Plasma...